...
首页> 外文期刊>Journal of cardiovascular medicine >α-Tocopherol and ascorbic acid in early postoperative period of cardiopulmonary bypass
【24h】

α-Tocopherol and ascorbic acid in early postoperative period of cardiopulmonary bypass

机译:体外循环术后早期的α-生育酚和抗坏血酸

获取原文
获取原文并翻译 | 示例

摘要

AIM: To investigate whether α-tocopherol and ascorbic acid have effect on the suppression of inflammation in the early postoperative period after open heart surgery. METHODS: A total of 59 patients who had undergone cardiopulmonary bypass (CPB) in the Cardiovascular Surgery Department of a tertiary center between June 2008 and December 2008 were retrospectively investigated. The study group consisted of 34 patients (25 men, 9 women) to whom ascorbic acid (500mg/day) and α-tocopherol (300mg/day) were administered on the day of operation (0th day) and the first four consecutive postoperative days. In contrast, 25 controls (20 men, 5 women) received no additional anti-inflammatory medications. The two groups were compared in terms of demographics, blood parameters such as C-reactive protein (CRP) and white blood cell (WBC) count, and durations of cross-clamp and CPB. RESULTS: In the control group, CRP levels were found to be increased on the first postoperative day (P<0.001) and CRP levels were correlated with triglyceride levels on the day of operation (P=0.009) and the first postoperative day (P=0.021). On the second postoperative day WBC count was found to be decreased (P=0.008) and correlated with glucose level (P<0.005). In the study group, CRP levels were found to be inversely correlated with serum high-density lipoprotein (HDL) (P=0.049) on the first postoperative day and directly correlated with triglyceride levels on the second postoperative day (P=0.017). Blood glucose levels were found to be increased on the first postoperative day (P=0.021) and a correlation was detected between WBC count on the fourth postoperative day and doses of ascorbic acid and α-tocopherol (P=0.027). CONCLUSION: Suppression of the systemic inflammatory response to CPB is a double-edged sword and whether this suppression aids in the attenuation of morbidity and mortality is obscure. In this respect, ascorbic acid and α-tocopherol seem to display some anti-inflammatory effect, but further studies are necessary to reveal the actual therapeutic potential and the complex mechanism related to biochemical and inflammatory parameters.
机译:目的:探讨α-生育酚和抗坏血酸对心脏直视术后术后早期炎症的抑制作用。方法:回顾性分析了2008年6月至2008年12月在三级中心心血管外科接受过体外循环(CPB)的59例患者。研究组包括34例患者(25例男性,9例女性),在手术当天(第0天)和术后连续第4天给予抗坏血酸(500mg /天)和α-生育酚(300mg /天)。 。相反,有25名对照(20名男性,5名女性)未接受其他抗炎药。比较了两组的人口统计学,血液参数(例如C反应蛋白(CRP)和白细胞(WBC)计数)以及交叉钳位和CPB的持续时间。结果:在对照组中,术后第一天CRP水平升高(P <0.001),并且在手术当天(P = 0.009)和术后第一天CRP水平与甘油三酸酯水平相关(P = 0.021)。术后第二天发现白细胞计数减少(P = 0.008)并与葡萄糖水平相关(P <0.005)。在研究组中,术后第一天CRP水平与血清​​高密度脂蛋白(HDL)呈负相关(P = 0.049),术后第二天CRP水平与甘油三酸酯水平直接相关(P = 0.017)。术后第一天血糖水平升高(P = 0.021),术后第四天白细胞计数与抗坏血酸和α-生育酚剂量之间存在相关性(P = 0.027)。结论:对CPB的全身性炎症反应的抑制是一把双刃剑,这种抑制是否有助于减轻发病率和死亡率尚不清楚。在这方面,抗坏血酸和α-生育酚似乎显示出一定的抗炎作用,但是需要进一步的研究来揭示其实际的治疗潜力以及与生化和炎症参数有关的复杂机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号